Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Nsc 617668
1. 123884-00-4
2. Dolostatin 15
3. J9zks885h5
4. Nsc 617668
5. (s)-1-((s)-2-benzyl-3-methoxy-5-oxo-2,5-dihydro-1h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl N-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-l-prolinate
6. L-proline, N,n-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-, (1s)-1-[[(2s)-2,5-dihydro-3-methoxy-5-oxo-2-(phenylmethyl)-1h-pyrrol-1-yl]carbonyl]-2-methylpropyl Ester
7. Nsc-617668
8. L-proline, N,n-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-, (1s)-1-(((2s)-2,5-dihydro-3-methoxy-5-oxo-2-(phenylmethyl)-1h-pyrrol-1-yl)carbonyl)-2-methylpropyl Ester
9. Mfcd00236968
10. Unii-j9zks885h5
11. Dolastatin 15, >=95%
12. Chembl35769
13. Schembl187502
14. Dls-15
15. Dtxsid30924629
16. Hy-p1126
17. Bdbm50472220
18. Zinc95611960
19. Cs-0027988
20. J-004993
21. [(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl] (2s)-1-[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylate
22. L-proline, 1-(1-(n-(n-(n,n-dimethyl-l-valyl)-l-valyl)-n-methyl-l-valyl)-l-prolyl)-, 1-((2,5-dihydro-3-methoxy-5-oxo-2-(phenylmethyl)-1h-pyrrol-1-yl)carbonyl)-2-methylpropyl Ester, (s-(r*,r*))-
23. L-proline, 1-(1-(n-(n-(n,n-dimethyl-l-valyl)-l-valyl)-n-methyl-l-valyl)-l-propyl)-, 1-((2,5-dihydro-3-methoxy-5-oxo-2-(phenylmethyl)-1h-pyrrol-1-yl)carbonyl)-2-methylpropyl Ester, (s-(r*,r*))-
| Molecular Weight | 837.1 g/mol |
|---|---|
| Molecular Formula | C45H68N6O9 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 18 |
| Exact Mass | 836.50477777 g/mol |
| Monoisotopic Mass | 836.50477777 g/mol |
| Topological Polar Surface Area | 166 Ų |
| Heavy Atom Count | 60 |
| Formal Charge | 0 |
| Complexity | 1600 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dolastatin 15 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dolastatin 15, including repackagers and relabelers. The FDA regulates Dolastatin 15 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dolastatin 15 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dolastatin 15 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dolastatin 15 supplier is an individual or a company that provides Dolastatin 15 active pharmaceutical ingredient (API) or Dolastatin 15 finished formulations upon request. The Dolastatin 15 suppliers may include Dolastatin 15 API manufacturers, exporters, distributors and traders.
click here to find a list of Dolastatin 15 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Dolastatin 15 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dolastatin 15 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dolastatin 15 GMP manufacturer or Dolastatin 15 GMP API supplier for your needs.
A Dolastatin 15 CoA (Certificate of Analysis) is a formal document that attests to Dolastatin 15's compliance with Dolastatin 15 specifications and serves as a tool for batch-level quality control.
Dolastatin 15 CoA mostly includes findings from lab analyses of a specific batch. For each Dolastatin 15 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dolastatin 15 may be tested according to a variety of international standards, such as European Pharmacopoeia (Dolastatin 15 EP), Dolastatin 15 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dolastatin 15 USP).
LOOKING FOR A SUPPLIER?
